Bank of New York Mellon’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-108,585
| Closed | -$3.04M | – | 4775 |
|
|
2022
Q1 | $3.04M | Sell |
108,585
-324
| -0.3% | -$8.88K | ﹤0.01% | 2697 |
|
|
2021
Q4 | $2.98M | Buy |
108,909
+1,472
| +1% | +$39.9K | ﹤0.01% | 2750 |
|
|
2021
Q3 | $2.92M | Sell |
107,437
-1,185
| -1% | -$29.3K | ﹤0.01% | 2778 |
|
|
2021
Q2 | $1.86M | Sell |
108,622
-22,000
| -17% | -$412K | ﹤0.01% | 3029 |
|
|
2021
Q1 | $2.73M | Sell |
130,622
-38,658
| -23% | -$892K | ﹤0.01% | 2748 |
|
|
2020
Q4 | $3.88M | Sell |
169,280
-4,882
| -3% | -$93K | ﹤0.01% | 2481 |
|
|
2020
Q3 | $2.84M | Sell |
174,162
-1,127
| -0.6% | -$20.4K | ﹤0.01% | 2482 |
|
|
2020
Q2 | $2.37M | Sell |
175,289
-329
| -0.2% | -$3.83K | ﹤0.01% | 2579 |
|
|
2020
Q1 | $2.08M | Buy |
175,618
+19,569
| +13% | +$434K | ﹤0.01% | 2522 |
|
|
2019
Q4 | $3.89M | Buy |
156,049
+2,638
| +2% | +$53.5K | ﹤0.01% | 2461 |
|
|
2019
Q3 | $2.61M | Sell |
153,411
-5,141
| -3% | -$93.6K | ﹤0.01% | 2608 |
|
|
2019
Q2 | $3.61M | Buy |
158,552
+4,427
| +3% | +$119K | ﹤0.01% | 2490 |
|
|
2019
Q1 | $4.96M | Buy |
154,125
+5,728
| +4% | +$177K | ﹤0.01% | 2336 |
|
|
2018
Q4 | $4.18M | Buy |
148,397
+3,595
| +2% | +$105K | ﹤0.01% | 2404 |
|
|
2018
Q3 | $4.16M | Buy |
144,802
+4,756
| +3% | +$143K | ﹤0.01% | 2489 |
|
|
2018
Q2 | $5.25M | Sell |
140,046
-52,505
| -27% | -$2.06M | ﹤0.01% | 2365 |
|
|
2018
Q1 | $7.57M | Buy |
192,551
+36,489
| +23% | +$1.33M | ﹤0.01% | 2138 |
|
|
2017
Q4 | $5.06M | Sell |
156,062
-25,190
| -14% | -$755K | ﹤0.01% | 2359 |
|
|
2017
Q3 | $5.64M | Sell |
181,252
-3,865
| -2% | -$114K | ﹤0.01% | 2283 |
|
|
2017
Q2 | $5.17M | Buy |
185,117
+34,577
| +23% | +$783K | ﹤0.01% | 2318 |
|
|
2017
Q1 | $2.58M | Buy |
150,540
+14,659
| +11% | +$205K | ﹤0.01% | 2696 |
|
|
2016
Q4 | $1.64M | Buy |
135,881
+36,991
| +37% | +$479K | ﹤0.01% | 2969 |
|
|
2016
Q3 | $1.57M | Buy |
98,890
+6,157
| +7% | +$92.7K | ﹤0.01% | 2918 |
|
|
2016
Q2 | $1.2M | Sell |
92,733
-14,666
| -14% | -$230K | ﹤0.01% | 3029 |
|
|
2016
Q1 | $2.04M | Buy |
107,399
+5,986
| +6% | +$108K | ﹤0.01% | 2647 |
|
|
2015
Q4 | $2.28M | Sell |
101,413
-32,287
| -24% | -$638K | ﹤0.01% | 2639 |
|
|
2015
Q3 | $3.13M | Buy |
133,700
+11,039
| +9% | +$305K | ﹤0.01% | 2490 |
|
|
2015
Q2 | $3.51M | Buy |
122,661
+73,427
| +149% | +$1.92M | ﹤0.01% | 2570 |
|
|
2015
Q1 | $1.27M | Buy |
49,234
+30,889
| +168% | +$706K | ﹤0.01% | 3155 |
|
|
2014
Q4 | $341K | Buy |
18,345
+7,596
| +71% | +$137K | ﹤0.01% | 3741 |
|
|
2014
Q3 | $166K | Buy |
+10,749
| New | +$162K | ﹤0.01% | 3930 |
|
Bank of New York Mellon's XENT Position: Q2 2022 in Review
Bank of New York Mellon sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 108,585 shares — an estimated $3.04M sold.
Bank of New York Mellon first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $7.57M in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Bank of New York Mellon reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Bank of New York Mellon sold 108,585 Intersect ENT, Inc shares in Q2 2022, an estimated $3.04M.
- Bank of New York Mellon first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
- Bank of New York Mellon's Intersect ENT, Inc position peaked at $7.57M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.